The National CT Colonography Trial: Multicenter Assessment of Accuracy for Detection of Large Adenomas and Cancers in a Healthy Screening Population
The National CT Colonography Trial: Multicenter Assessment of Accuracy for Detection of Large Adenomas and Cancers in a Healthy Screening Population
RATIONALE: New diagnostic procedures such as computed tomographic colonography may improve the ability to detect colorectal cancer and may provide a less invasive method of detection.
PURPOSE: This clinical trial is studying how well computed tomographic colonography works in screening healthy participants for colorectal cancer.
OBJECTIVES:
Primary
Secondary
OUTLINE: This is a multicenter study.
Participants receive an oral laxative, oral bisacodyl, and three doses of oral barium sulphate 24 hours before imaging. After cathartic cleansing, participants undergo computed tomographic colonography followed by colonoscopy.
Participants are followed up for approximately 4 weeks.
PROJECTED ACCRUAL: A total of 2,607 participants will be accrued for this study.
Inclusion Criteria
Exclusion Criteria
Symptoms of disease of the lower gastrointestinal tract, including
Inflammatory bowel disease and/or familial polyposis syndrome
Serious medical conditions that would increase the risk associated with colonoscopy or are so severe that screening would have no benefit
Pregnancy
Previous colonoscopy within the past five years
Anemia (hemoglobin less than 10 gm/dl)
Positive fecal occult blood test (FOBT)
Baltimore, Maryland 21231-2410, United States
St Louis, Missouri 63110, United States